Immune Regulation News Volume 15.48 | Dec 15 2023

    0
    9








    2023-12-15 | IRN 15.48


    Immune Regulation News by STEMCELL Technologies
    Vol. 15.48 – 15 December, 2023
    TOP STORY

    Age-Associated Senescent – T Cell Signaling Promotes Type 3 Immunity that Inhibits the Biomaterial Regenerative Response

    Investigators characterized how aging induced changes in immunological signatures that inhibited tissue repair and therapeutic response to a clinical regenerative biological scaffold derived from extracellular matrix.
    [Advanced Materials]

    Abstract
    Explore how immune cell isolation can be made easy
    PUBLICATIONSRanked by the impact factor of the journal

    Screening for Lipid Nanoparticles That Modulate the Immune Activity of Helper T Cells towards Enhanced Antitumor Activity

    The authors reported a lipid nanoparticle-screening method for the optimization of the type of helper lipid and of lipid-component ratios to enhance the delivery of tumor-antigen-encoding mRNA to dendritic cells and their immune-activation profile towards enhanced antitumor activity.
    [Nature Biomedical Engineering]

    Abstract

    The BCL-2 Inhibitor APG-2575 Resets Tumor-Associated Macrophages toward the M1 Phenotype, Promoting a Favorable Response to Anti-PD-1 Therapy via NLRP3 Activation

    Using single-cell RNA sequencing, researchers found that APG-2575 polarized M2-like immunosuppressive macrophages toward the M1-like immunostimulatory phenotype with increased CCL5 and CXCL10 secretion, restoring T cell function and promoting a favorable immunotherapy response.
    [Cellular & Molecular Immunology]

    Full Article

    Interleukin-9 Production by Type 2 Innate Lymphoid Cells Induces Paneth Cell Metaplasia and Small Intestinal Remodeling

    Investigators described the development of Paneth cell metaplasia in a murine model of chronic myelogenous leukemia that was driven by an inducible bcr-abl oncogene.
    [Nature Communications]

    Full Article

    Inhibition of ACLY Overcomes Cancer Immunotherapy Resistance via Polyunsaturated Fatty Acids Peroxidation and cGAS-STING Activation

    Scientists showed that adenosine 5′-triphosphate citrate lyase (ACLY) inhibition up-regulated programmed death ligand 1 immune checkpoint expression in cancer cells and induced T cell dysfunction to drive immunosuppression and compromise its antitumor effect in immunocompetent mice.
    [Science Advances]

    Full Article

    Soluble CTLA-4 Attenuates T Cell Activation and Modulates Anti-Tumor Immunity

    The authors explored the functional properties of sCTLA-4 and evaluated the efficacy of isoform-specific anti-sCTLA-4 antibody targeting in murine cancer model.
    [Molecular Therapy]

    AbstractGraphical Abstract

    Immune Modulation of Innate and Adaptive Responses Restores Immune Surveillance and Establishes Anti-Tumor Immunological Memory

    Using a mouse model of ovarian cancer, researchers demonstrated the oncolytic effect and immune-modulatory capacities of CARG-2020.
    [Cancer Immunology Research]

    Abstract

    CD62L Expression Marks a Functionally Distinct Subset of Memory B Cells

    The authors showed that CD62L and CD44 were progressively expressed on mouse memory B cells and identified transcriptionally and functionally distinct memory B cell subsets.
    [Cell Reports]

    Full ArticleGraphical Abstract

    BLK Positively Regulates TLR/IL-1R Signaling by Catalyzing TOLLIP Phosphorylation

    Scientists showed that B lymphoid tyrosine kinase (BLK) positively regulated TLR/IL-1R–mediated inflammatory response. BLK-deficient mice produced less inflammatory cytokines and were more resistant to death upon IL-1β challenge.
    [Journal of Cell Biology]

    Full Article
    STEMCELL has implemented an Environmental Management System that is now ISO 14001-certified.
    REVIEWS

    Ubiquitin Signaling in Drosophila Innate Immune Responses

    Investigators summarize the molecular signaling pathways regulating immune responses to pathogen infection in Drosophila, with a focus on ubiquitin-dependent control of innate immunity and inflammatory signaling.
    [FEBS Journal]

    Abstract
    INDUSTRY AND POLICY NEWS

    Parker Institute for Cancer Immunotherapy (PICI) Welcomes Weill Cornell Medicine to Cancer Research Consortium

    PICI announced it has added Weill Cornell Medicine to its network of preeminent academic and medical research institutions at the forefront of the fight against cancer.
    [Weill Cornell Medicine]

    Press Release
    FEATURED EVENT

    2024 Immunoengineering Conference GRC

    February 11 – 16, 2023
    Barga, Italy

    > See All Events

    JOB OPPORTUNITIES

    Research Fellow – Immunology

    University of Surrey – Surrey, England, United Kingdom

    PhD Positions – Tissue Regeneration and Cancer Immunotherapy

    Albert-Ludwigs-University Freiburg – Freiburg im Breisgau, Germany

    Postdoctoral Fellow – Pathogen Immune Response

    Francis Crick Institute – London, England, United Kingdom

    Postdoctoral Scientists – Regulatory Lymphocytes & Tissue Resident Cells Crosstalk

    Institut Necker Enfants Malades – Paris, France

    Postdoctoral Position – Inflammation/Regeneration

    Institut Pasteur – Paris, France

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2